The levels of these products are >700- and >30-fold higher in patients with DMD and BMD, respectively, compared with healthy individuals, suggesting that urinary titin may be a biomarker for muscle degeneration (10). The gene discussed is TTN; the disease is Duchenne muscular dystrophy.